Skip to main content
Clinical Trials/NCT05442606
NCT05442606
Completed
N/A

Effect of Adding Physiotherapy Program to the Conservative Medical Therapy on Quality of Life and Pain Threshold in Chronic Rhinosinusitis Patients: A Prospective Randomized Controlled Trial

Cairo University1 site in 1 country68 target enrollmentSeptember 1, 2022
ConditionsRhinosinusitis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rhinosinusitis
Sponsor
Cairo University
Enrollment
68
Locations
1
Primary Endpoint
Rhinosinusitis Disability Index (RSDI)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study aims to investigate the effect of adding of integrated physiotherapy program to the conservative medical therapy on quality of life and pressure pain threshold (PPT) in chronic rhinosinusitis patients. Patients in this study will be randomly assigned into 2 groups. Group A (control group) will receive conservative medical treatment only which prescribed by Ear, Nose and Throat (ENT) specialist, while group B (experimental group) will receive the conservative medical treatment prescribed by ENT specialist in addition to physiotherapy program. Quality of Life (QoL) will be evaluated by Rhinosinusitis Disability Index (RSDI) and PPT will be evaluated by digital algometer at the baseline and immediately after the end of tenth session of treatment for both groups.

Detailed Description

Sixty-eight patients will be recruited for this study from Al-Qurayyat General Hospital in Al-Jouf Region, Saudi Arabia, with the following inclusion criteria: patients of both sexes, aged from 30 to 50 years, diagnosed by ENT specialist, with chronic rhinosinusitis with a history of 3 months or longer. The patients will be allocated into two equal groups at random (n = 34). Group A (control group) will receive medication only which prescribed by ENT specialist. Group B (experimental group) will receive prescribed medication by ENT specialist in addition to physiotherapy program which consists of: Ultrasound Therapy: The patients will receive pulsed (duty cycle 50%) US therapy with an intensity of 1 and 0.5 W/cm2 for maxillary and frontal sinus, respectively, with a frequency of 1MHz collimating beam. The small probe US applicator (0.8 cm2) with effective radiating area (ERA) equal 0.6 cm2 and beam non-uniformity ratio (BNR) equal 6:1 will be used to deliver US to the treatment area. The area of US application will be the skin over the cheeks for maxillary sinus and forehead for the frontal sinus. Ultrasound transmission gel will be used between the applicator and the skin, full contact technique in slow circular motion will be used for the duration of 5 minutes over the maxillary sinuses and 4 minutes over the frontal sinuses on each pair of sinuses. Manual Drainage Techniques: for the frontal and maxillary sinuses. Self Massaging Technique: The patients will also advised to perform self-massaging for the frontal and maxillary sinuses from the supine lying position. A demonstration session will be used to provide patients in the experimental group with a full description of the manual therapy procedure before the beginning of the study. The physiotherapy program will be applied 3 times a week (day after day) for 12 treatment sessions.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
March 21, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Khaled Z. Fouda

Associate Professor of Physical therapy

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patients of both sexes
  • Aged from 30 to 50 years
  • Cynically diagnosed by Ear, Nose, and Throat (ENT) specialist, with chronic rhinosinusitis with a history of more than 3 months, confirmed by clinical diagnostic criteria (more than or equal to two major symptoms or one major symptom (nasal obstruction, facial pain/pressure, postnasal drip and hyposmia) and two minor symptoms (headache, halitosis, fatigue, dental pain and ear pain) and also verified by Computed Tomography (CT) scan results .
  • Exclusion criteria:
  • Having any tumors or cysts (as confirmed by CT scan)
  • Nasal polyps
  • Facial skin lesions or diseases or allergies of the face
  • Pregnancy
  • Metal implants in the face region
  • Previous nasal surgical procedures

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Rhinosinusitis Disability Index (RSDI)

Time Frame: From baseline to 4 weeks after treatment (immediately after the completion of session 12)

Arabic version of Rhinosinusitis Disability Index will be used to assess the change in quality of life

Secondary Outcomes

  • Pressure pain threshold(From baseline to 4 weeks after treatment (immediately after the completion of session 12))

Study Sites (1)

Loading locations...

Similar Trials